These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 1634043)
1. The diffusion of new genetic tests for predicting disease. Holtzman NA FASEB J; 1992 Jul; 6(10):2806-12. PubMed ID: 1634043 [TBL] [Abstract][Full Text] [Related]
2. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. American Society of Clinical Oncology J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171 [TBL] [Abstract][Full Text] [Related]
3. Effect of the Human Genome Initiative on women's rights and reproductive decisions. Charo RA Fetal Diagn Ther; 1993 Apr; 8(Suppl. 1):148-59. PubMed ID: 11653014 [TBL] [Abstract][Full Text] [Related]
4. Primary care physicians as providers of frontline genetic services. Holtzman NA Fetal Diagn Ther; 1993 Apr; 8 Suppl 1():213-9. PubMed ID: 8512648 [TBL] [Abstract][Full Text] [Related]
5. Public policy implications of human genetic technology: genetic screening. Blank RH J Med Philos; 1982 Nov; 7(4):355-74. PubMed ID: 6820957 [TBL] [Abstract][Full Text] [Related]
6. Newborn screening for genetic disorders. Fernhoff PM Pediatr Clin North Am; 2009 Jun; 56(3):505-13, Table of Contents. PubMed ID: 19501689 [TBL] [Abstract][Full Text] [Related]
7. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996. J Clin Oncol; 1996 May; 14(5):1730-6; discussion 1737-40. PubMed ID: 8622094 [TBL] [Abstract][Full Text] [Related]
8. Genetic screening: programs, principles, and research--thirty years later. Reviewing the recommendations of the Committee for the Study of Inborn Errors of Metabolism (SIEM). Simopoulos AP; Public Health Genomics; 2009; 12(2):105-11. PubMed ID: 19039254 [TBL] [Abstract][Full Text] [Related]
9. Benefits and risks of emerging genetic technologies: the need for regulation. Holtzman NA Clin Chem; 1994 Aug; 40(8):1652-7. PubMed ID: 8045024 [TBL] [Abstract][Full Text] [Related]
10. When genetic screening is useful, but not used. Bernhardt BA; Pyeritz RE LDI Issue Brief; 2011; 16(8):1-4. PubMed ID: 21863606 [TBL] [Abstract][Full Text] [Related]
11. Genetic screening, testing and treatment: how far can we go? Scriver CR J Inherit Metab Dis; 1996; 19(4):401-11. PubMed ID: 8884564 [TBL] [Abstract][Full Text] [Related]
12. Genetic screening raises questions for employers and insurers. Kolata G Science; 1986 Apr; 232(4748):317-9. PubMed ID: 2938255 [TBL] [Abstract][Full Text] [Related]
13. The genetic testing of children. Working Party of the Clinical Genetics Society (UK). Clarke A J Med Genet; 1994 Oct; 31(10):785-97. PubMed ID: 7837256 [No Abstract] [Full Text] [Related]
14. The clinical geneticist and the "new genetics". Haan EA Med J Aust; 2003 May; 178(9):458-62. PubMed ID: 12720515 [TBL] [Abstract][Full Text] [Related]
16. The quest for the perfect baby: why do Israeli women seek prenatal genetic testing? Remennick L Sociol Health Illn; 2006 Jan; 28(1):21-53. PubMed ID: 16509941 [TBL] [Abstract][Full Text] [Related]
17. Ethical issues in screening and testing for genetic diseases. Kadlec JV; McPherson RA Clin Lab Med; 1995 Dec; 15(4):989-99. PubMed ID: 8838235 [TBL] [Abstract][Full Text] [Related]
18. Good laboratory practices for biochemical genetic testing and newborn screening for inherited metabolic disorders. Centers for Disease Control and Prevention (CDC) MMWR Recomm Rep; 2012 Apr; 61(RR-2):1-44. PubMed ID: 22475884 [TBL] [Abstract][Full Text] [Related]
19. Public health impact of genetic tests at the end of the 20th century. Yoon PW; Chen B; Faucett A; Clyne M; Gwinn M; Lubin IM; Burke W; Khoury MJ Genet Med; 2001; 3(6):405-10. PubMed ID: 11715004 [TBL] [Abstract][Full Text] [Related]
20. Bringing genetic tests into the clinic. Holtzman NA Hosp Pract (1995); 1998 Jan; 33(1):107-12, 115-6, 121-2 passim. PubMed ID: 9464234 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]